Identification of novel human papillomavirus lineages and sublineages in HIV/HPV-coinfected pregnant women by next-generation sequencing

Virology

Volumn 493, Issue , 2016, Pages 202-208

  Siqueira, Juliana D ^a   Alves, Brunna M ^a   Prellwitz, Isabel M ^a   Furtado, Carolina ^a   Meyrelles, Ângela R ^b   Machado, Elizabeth S ^b   Seuánez, Héctor N ^b   Soares, Marcelo A ^a,b   Soares, Esmeralda A ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Coinfection; Full length sequence; High risk types; HPV; Immunosuppression; Pregnancy

Indexed keywords

ADULT; ARTICLE; CELL LINEAGE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENETIC DISTANCE; GENOME; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MIXED INFECTION; MOLECULAR CLONING; NEXT GENERATION SEQUENCING; NONHUMAN; PATHOPHYSIOLOGY; PHYLOGENY; PREGNANT WOMAN; PRIORITY JOURNAL; VERRUCA VULGARIS; VIRUS ASSEMBLY; VIRUS GENOME; VIRUS IDENTIFICATION; WART VIRUS; CLASSIFICATION; COMPLICATION; GENETICS; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PREGNANCY; PREGNANCY COMPLICATION; VIROLOGY;

ADULT; COHORT STUDIES; COINFECTION; FEMALE; GENOME, VIRAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV INFECTIONS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84962142405     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2016.03.027     Document Type: Article

References (61)

1. Ameur A., Meiring T.L., Bunikis I., Haggqvist S., Lindau C., Lindberg J.H., Gustavsson I., Mbulawa Z.Z., Williamson A.L., Gyllensten U. Comprehensive profiling of the vaginal microbiome in HIV positive women using massive parallel semiconductor sequencing. Sci. Rep. 2014, 4:4398.
2. Armbruster-Moraes E., Ioshimoto L.M., Leao E., Zugaib M. Prevalence of 'high risk' human papillomavirus in the lower genital tract of Brazilian gravidas. Int. J. Gynaecol. Obstet. 2000, 69:223-227.
3. Barzon L., Militello V., Lavezzo E., Franchin E., Peta E., Squarzon L., Trevisan M., Pagni S., Dal Bello F., Toppo S., Palu G. Human papillomavirus genotyping by 454 next generation sequencing technology. J. Clin. Virol. 2011, 52:93-97.
4. Beachler D.C., Weber K.M., Margolick J.B., Strickler H.D., Cranston R.D., Burk R.D., Wiley D.J., Minkoff H., Reddy S., Stammer E.E., Gillison M.L., D'Souza G. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol. Biomark. Prev. 2012, 21:122-133.
5. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
6. Berumen J., Ordonez R.M., Lazcano E., Salmeron J., Galvan S.C., Estrada R.A., Yunes E., Garcia-Carranca A., Gonzalez-Lira G., Madrigal-de la Campa A. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 2001, 93:1325-1330.
7. Bruni, L., Barrionuevo-Rosas, L., Albero, G., Aldea, M., Serrano, B., Valencia, S., Brotons, M., Mena, M., Cosano, R., Muñoz, J., Bosch, F.X., de Sanjosé, S., Castellsagué, X., 2015. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 2015-04-08. (accessed 2015-10-02).
8. Burk R.D., Harari A., Chen Z. Human papillomavirus genome variants. Virology 2013, 445:232-243.
9. Burk R.D., Terai M., Gravitt P.E., Brinton L.A., Kurman R.J., Barnes W.A., Greenberg M.D., Hadjimichael O.C., Fu L., McGowan L., Mortel R., Schwartz P.E., Hildesheim A. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res. 2003, 63:7215-7220.
10. Bzhalava D., Muhr L.S., Lagheden C., Ekstrom J., Forslund O., Dillner J., Hultin E. Deep sequencing extends the diversity of human papillomaviruses in human skin. Sci. Rep. 2014, 4:5807.
11. Camargo M., Soto-De Leon S.C., Munoz M., Sanchez R., Pena-Herrera D., Pineda-Pena A.C., Sussmann O., Paez C., Perez-Prados A., Patarroyo M.E., Patarroyo M.A. Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia. BMC Cancer 2014, 14:451.
12. Campos R.R., Melo V.H., Castilho D.M., Nogueira C.P.F. Prevalence of human papillomavirus and its genotypes in the uterine cervix of HIV-infected and non-infected women. Rev. Bras. Ginecol. Obstet. 2005, 27:248-256.
13. Chen A.A., Heideman D.A., Boon D., Chen Z., Burk R.D., De Vuyst H., Gheit T., Snijders P.J., Tommasino M., Franceschi S., Clifford G.M. Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer. Virology 2014, 448:356-362.
14. Chen A.A., Heideman D.A., Boon D., Gheit T., Snijders P.J., Tommasino M., Franceschi S., Clifford G.M. Human papillomavirus 45 genetic variation and cervical cancer risk worldwide. J. Virol. 2014, 88:4514-4521.
15. Chen Z., Schiffman M., Herrero R., Desalle R., Anastos K., Segondy M., Sahasrabuddhe V.V., Gravitt P.E., Hsing A.W., Burk R.D. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One 2011, 6:e20183.
16. Cornet I., Gheit T., Iannacone M.R., Vignat J., Sylla B.S., Del Mistro A., Franceschi S., Tommasino M., Clifford G.M. HPV16 genetic variation and the development of cervical cancer worldwide. Br. J. Cancer 2013, 108:240-244.
17. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
18. Fife K.H., Katz B.P., Roush J., Handy V.D., Brown D.R., Hansell R. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am. J. Obstet. Gynecol. 1996, 174:1487-1493.
19. Freitas L.B., Chen Z., Muqui E.F., Boldrini N.A., Miranda A.E., Spano L.C., Burk R.D. Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions. PLoS One 2014, 9:e100746.
20. Garbuglia A.R., Piselli P., Lapa D., Sias C., Del Nonno F., Baiocchini A., Cimaglia C., Agresta A., Capobianchi M.R. Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy. J. Clin. Virol. 2012, 54:141-146.
21. Godinez J.M., Heideman D.A., Gheit T., Alemany L., Snijders P.J., Tommasino M., Meijer C.J., de Sanjose S., Bosch F.X., Bravo I.G. Differential presence of Papillomavirus variants in cervical cancer: an analysis for HPV33, HPV45 and HPV58. Infect. Genet. Evol. 2013, 13:96-104.
22. Goncalves M.A., Massad E., Burattini M.N., Villa L.L. Relationship between human papillomavirus (HPV) genotyping and genital neoplasia in HIV-positive patients of Santos City, Sao Paulo, Brazil. Int. J. STD AIDS 1999, 10:803-807.
23. Guindon S., Dufayard J.F., Lefort V., Anisimova M., Hordijk W., Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 2010, 59:307-321.
24. Hernandez-Giron C., Smith J.S., Lorincz A., Lazcano E., Hernandez-Avila M., Salmeron J. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico. Sex. Transm. Dis. 2005, 32:613-618.
25. Hessol N.A., Holly E.A., Efird J.T., Minkoff H., Weber K.M., Darragh T.M., Burk R.D., Strickler H.D., Greenblatt R.M., Palefsky J.M. Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women. AIDS 2013, 27:1743-1751.
26. Hildesheim A., Schiffman M., Bromley C., Wacholder S., Herrero R., Rodriguez A., Bratti M.C., Sherman M.E., Scarpidis U., Lin Q.Q., Terai M., Bromley R.L., Buetow K., Apple R.J., Burk R.D. Human papillomavirus type 16 variants and risk of cervical cancer. J. Natl. Cancer Inst. 2001, 93:315-318.
27. Jalil E.M., Bastos F.I., Melli P.P., Duarte G., Simoes R.T., Yamamoto A.Y., Morais R.A., Quintana S.M. HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study. BMC Infect. Dis. 2013, 13:564.
28. Johansson H., Bzhalava D., Ekstrom J., Hultin E., Dillner J., Forslund O. Metagenomic sequencing of "HPV-negative" condylomas detects novel putative HPV types. Virology 2013, 440:1-7.
29. Joshi, N.A., Fass, J.N., 2011. Sickle: A sliding-window, adaptive, quality-based trimming tool for FastQ files (Version 1.33) (Software). Available at . http://https://github.com/najoshi/sickle.
30. Keane T.M., Creevey C.J., Pentony M.M., Naughton T.J., McLnerney J.O. Assessment of methods for amino acid matrix selection and their use on empirical data shows that ad hoc assumptions for choice of matrix are not justified. BMC Evol. Biol. 2006, 6:29.
31. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
32. Leibenson L., Banani S., Borer A., Meirovitz M., Avni Y.S., Singer D., Schlaeffer F., Leibenson M., Silberstein T., Wiznitzer A., Riesenberg K. The prevalence of human papillomavirus and cervical cytology abnormalities in women infected with human immunodeficiency virus in southern Israel. Isr. Med. Assoc. J. 2011, 13:34-38.
33. Levi J.E., Fernandes S., Tateno A.F., Motta E., Lima L.P., Eluf-Neto J., Pannuti C.S. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol. Oncol. 2004, 92:225-231.
34. Levi J.E., Kleter B., Quint W.G., Fink M.C., Canto C.L., Matsubara R., Linhares I., Segurado A., Vanderborght B., Neto J.E., Van Doorn L.J. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J. Clin. Microbiol. 2002, 40:3341-3345.
35. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760.
36. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. The sequence alignment/map format and SAMtools. Bioinformatics 2009, 25:2078-2079.
37. Lima M.D., Braz-Silva P.H., Pereira S.M., Riera C., Coelho A.C., Gallottini M. Oral and cervical HPV infection in HIV-positive and HIV-negative women attending a sexual health clinic in Sao Paulo, Brazil. Int. J. Gynaecol. Obstet. 2014, 126:33-36.
38. Londesborough P., Ho L., Terry G., Cuzick J., Wheeler C., Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int. J. Cancer 1996, 69:364-368.
39. Madeddu G., Mameli G., Capobianco G., Babudieri S., Maida I., Bagella P., Rocca G., Cherchi P.L., Sechi L.A., Zanetti S., Nunnari G., Dessole S., Mura M.S. HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART. Eur. Rev. Med. Pharmacol. Sci. 2014, 18:1277-1285.
40. McDonald A.C., Tergas A.I., Kuhn L., Denny L., Wright T.C. Distribution of human papillomavirus genotypes among HIV-positive and HIV-negative women in Cape Town, South Africa. Front. Oncol. 2014, 4:48.
41. McKenzie N.D., Kobetz E.N., Ganjei-Azar P., Rosa-Cunha I., Potter J.E., Morishita A., Lucci J.A., Guettouche T., Hnatyszyn J.H., Koru-Sengul T. HPV in HIV-infected women: implications for primary prevention. Front. Oncol. 2014, 4:179.
42. Meiring T.L., Salimo A.T., Coetzee B., Maree H.J., Moodley J., Hitzeroth I.I., Freeborough M.J., Rybicki E.P., Williamson A.L. Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits. Virol. J. 2012, 9:164.
43. Meyrelles A.R., Siqueira J.D., Hofer C.B., Costa T.P., Azevedo A.P., Guimaraes B.V., Seuanez H.N., Soares M.A., Almeida G., Soares E.A., Machado E.S. HIV/HPV co-infection during pregnancy in southeastern Brazil: prevalence, HPV types, cytological abnormalities and risk factors. Gynecol. Oncol. 2013, 128:107-112.
44. Meyrelles A.R., Siqueira J.D., Santos P.P., Hofer C.B., Luiz R.R., Seuanez H.N., Almeida G., Soares M.A., Soares E.A., Machado E.S. Bonafide, type-specific human papillomavirus persistence among HIV-positive pregnant women: predictive value for cytological abnormalities, a longitudinal cohort study. Memorias Inst. Oswaldo Cruz 2016, 111:120-127.
45. Nobbenhuis M.A., Helmerhorst T.J., van den Brule A.J., Rozendaal L., Bezemer P.D., Voorhorst F.J., Meijer C.J. High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. Br. J. Cancer 2002, 87:75-80.
46. Palle C., Bangsboll S., Andreasson B. Cervical intraepithelial neoplasia in pregnancy. Acta Obstet. Gynecol. Scand. 2000, 79:306-310.
47. Park E.K., Cho H., Lee S.H., Lee S.G., Lee S.Y., Kim K.H., Lee C.H., Chung J.S., Kwak I.S. Human papillomavirus prevalence and genotype distribution among HIV-infected women in Korea. J. Korean Med. Sci. 2014, 29:32-37.
48. Robinson J.T., Thorvaldsdottir H., Winckler W., Guttman M., Lander E.S., Getz G., Mesirov J.P. Integrative genomics viewer. Nat. Biotechnol. 2011, 29:24-26.
49. Schiffman M., Rodriguez A.C., Chen Z., Wacholder S., Herrero R., Hildesheim A., Desalle R., Befano B., Yu K., Safaeian M., Sherman M.E., Morales J., Guillen D., Alfaro M., Hutchinson M., Solomon D., Castle P.E., Burk R.D. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010, 70:3159-3169.
50. Sichero L., Ferreira S., Trottier H., Duarte-Franco E., Ferenczy A., Franco E.L., Villa L.L. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int. J. Cancer 2007, 120:1763-1768.
51. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
52. Vernon S.D., Reeves W.C., Clancy K.A., Laga M., St Louis M., Gary H.E., Jr, Ryder R.W., Manoka A.T., Icenogle J.P. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women. J. Infect. Dis. 1994, 169:1108-1112.
53. Villa L.L., Sichero L., Rahal P., Caballero O., Ferenczy A., Rohan T., Franco E.L. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 2000, 81:2959-2968.
54. Xi L.F., Koutsky L.A., Hildesheim A., Galloway D.A., Wheeler C.M., Winer R.L., Ho J., Kiviat N.B. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol. Biomarkers Prev. 2007, 16:4-10.
55. Xi L.F., Schiffman M., Koutsky L.A., He Z., Winer R.L., Hulbert A., Lee S.K., Ke Y., Kiviat N.B. Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage. Int. J. Cancer 2013, 132:549-555.
56. Xi L.F., Schiffman M., Koutsky L.A., Hughes J.P., Winer R.L., Mao C., Hulbert A., Lee S.K., Shen Z., Kiviat N.B. Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 2014, 106:1-10.
57. Xi L.F., Schiffman M., Koutsky L.A., Hulbert A., Lee S.K., Defilippis V., Shen Z., Kiviat N.B. Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3. Int. J. Cancer 2012, 131:2300-2307.
58. Yamada T., Wheeler C.M., Halpern A.L., Stewart A.C., Hildesheim A., Jenison S.A. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 1995, 69:7743-7753.
59. Zehbe I., Wilander E., Delius H., Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998, 58:829-833.
60. Zhang C., Park J.S., Grce M., Hibbitts S., Palefsky J.M., Konno R., Smith-McCune K.K., Giovannelli L., Chu T.Y., Picconi M.A., Pina-Sanchez P., Settheetham-Ishida W., Coutlee F., De Marco F., Woo Y.L., Ho W.C., Wong M.C., Chirenje M.Z., Magure T., Moscicki A.B., Sabol I., Fiander A.N., Chen Z., Chan M.C., Cheung T.H., Burk R.D., Chan P.K. Geographical distribution and risk association of human papillomavirus genotype 52-variant lineages. J. Infect. Dis. 2014, 210:1600-1604.
61. Zuna R.E., Moore W.E., Shanesmith R.P., Dunn S.T., Wang S.S., Schiffman M., Blakey G.L., Teel T. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int. J. Cancer 2009, 125:2609-2613.